- Home
- ONCY vs ANVS Comparison
ONCY vs ANVS Comparison
Compare ONCY & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- ANVS
- Stock Information
- Founded
- ONCY 1998
- ANVS 2008
- Country
- ONCY Canada
- ANVS United States
- Employees
- ONCY N/A
- ANVS N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- ONCY Health Care
- ANVS Health Care
- Exchange
- ONCY Nasdaq
- ANVS Nasdaq
- Market Cap
- ONCY 49.1M
- ANVS 54.6M
- IPO Year
- ONCY 1999
- ANVS 2020
- Fundamental
- Price
- ONCY $0.69
- ANVS $2.64
- Analyst Decision
- ONCY Strong Buy
- ANVS Strong Buy
- Analyst Count
- ONCY 4
- ANVS 5
- Target Price
- ONCY $4.33
- ANVS $30.25
- AVG Volume (30 Days)
- ONCY 1.4M
- ANVS 560.5K
- Earning Date
- ONCY 07-31-2025
- ANVS 08-14-2025
- Dividend Yield
- ONCY N/A
- ANVS N/A
- EPS Growth
- ONCY N/A
- ANVS N/A
- EPS
- ONCY N/A
- ANVS N/A
- Revenue
- ONCY N/A
- ANVS N/A
- Revenue This Year
- ONCY N/A
- ANVS N/A
- Revenue Next Year
- ONCY N/A
- ANVS N/A
- P/E Ratio
- ONCY N/A
- ANVS N/A
- Revenue Growth
- ONCY N/A
- ANVS N/A
- 52 Week Low
- ONCY $0.33
- ANVS $1.11
- 52 Week High
- ONCY $1.53
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- ONCY 69.96
- ANVS 54.28
- Support Level
- ONCY $0.56
- ANVS $2.73
- Resistance Level
- ONCY $0.37
- ANVS $3.08
- Average True Range (ATR)
- ONCY 0.07
- ANVS 0.32
- MACD
- ONCY 0.04
- ANVS -0.06
- Stochastic Oscillator
- ONCY 83.26
- ANVS 29.41
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.